Gregor Thomas, Ph.D., who brings years of experience in the orthopedic, oral surgery and reconstructive dentistry specialties, has been appointed as new Medical Director at curasan AG. He replaces Dr. Wolf-Dietrich Hübner, who will retire at the end of this year.
Gregor Thomas, Ph.D.: New Medical Director at curasan AG

Dr. Thomas will lead the medical affairs, clinical research, regulatory affairs and quality systems departments.
Dr. Thomas told OTW, “I studied medicine and dentistry and worked for some years as an assistant doctor in the department of Oro-Maxillo-Facial Surgery of the University Hospital in Würzburg. I did my Ph.D. in orthopedics, working on low grade infections of endoprosthetical implants. After about 15 years in my own practice, focused on surgery and functional diseases I started my first job in industry in R&D. My last projects were in bio glass development.
“We are very busy as the company has some new products and we are registering a very innovative product for bone regeneration on the American market. As the company is actually growing on different markets there is a huge effort for registration which requires new staff in the medical department. My first important goal of implementing a distributor for UK is just reached. Writing publications for magazines is another task, also nursing the contacts with our KOLs [key opinion leaders] and creating new contacts with universities. In a summary I can say that my daily business is pretty exciting and I am looking forward to the future with curasan.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.